A detailed history of Sjs Investment Consulting Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 2 shares of MRVI stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$10
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$6.87 - $11.34 $13 - $22
-2 Reduced 50.0%
2 $0
Q4 2023

Jan 16, 2024

BUY
$4.7 - $9.87 $4 - $9
1 Added 33.33%
4 $0
Q3 2023

Oct 17, 2023

SELL
$9.14 - $12.85 $18 - $25
-2 Reduced 40.0%
3 $0
Q2 2023

Jul 13, 2023

SELL
$12.09 - $15.0 $12 - $15
-1 Reduced 16.67%
5 $0
Q1 2023

Apr 20, 2023

BUY
$12.99 - $16.48 $38 - $49
3 Added 100.0%
6 $0
Q4 2022

Jan 23, 2023

BUY
$12.5 - $24.78 $25 - $49
2 Added 200.0%
3 $0
Q3 2022

Oct 13, 2022

BUY
$20.6 - $30.37 $20 - $30
1 New
1 $0

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Sjs Investment Consulting Inc. Portfolio

Follow Sjs Investment Consulting Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sjs Investment Consulting Inc. with notifications on news.